MedTrace Logo

Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma

NCT00192829 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2007-04-11

No results posted yet for this study

Summary

The association between cancer and thrombosis is well known and the occurrence of thrombotic complications is commonly associated with poor prognosis. The aim os this study is to determine the possible value of hypercoagulable parameters as prognostic parameters in advanced non-small cell lung carcinoma (NSCLC).

Conditions

  • Non-Small Cell Lung Carcinoma
  • Venous Thromboembolism

Interventions

PROCEDURE

Blood sample withdrawal

Sponsors & Collaborators

  • Rambam Health Care Campus

    lead OTHER

Principal Investigators

  • Galit Sarig, Ph.D · Rambam Health Care Campus

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-06-30

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00192829 on ClinicalTrials.gov